Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-47.88	15.39	29.54
Graham Fair Price	38.07	4.22	3.05
PEG	-73.37	0.01	-0.06
Price/Book	10.69	0.31	0.28
Price/Cash Flow	93.65	-12.37	-194.68
Prices/Earnings	-49.42	1.58	3.12
Price/Sales	-49.42	0.97	1.91
Price/FCF	93.65	-12.37	-194.68
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.39	0.39
Operating Margin	-1.69	0.29	0.29
ROA	104.39	0.02	< 0.005
ROE	0.02	0.05	118.85
ROIC	0.01	0.03	103.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.05	< 0.005	789.88
Dividends QOQ	0.09	< 0.005	-100.00
EBIT QOQ	-0.52	1.01	95.38
EPS QOQ	-0.56	1.06	89.93
FCF QOQ	0.98	-15.26	1460.03
Revenue QOQ	-0.40	1.04	157.45
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4.75	2.32	-51.07
Days Sales Outstanding (DSO)	327.55	178.12	-45.62
Inventory Turnover	18.94	38.72	104.39
Debt/Capitalization	0.56	0.59	5.25
Quick Ratio	1.08	1.18	8.55
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4.27	3.98	-6.67
Cash	0.70	0.70	-0.06
Capex	< 0.005	-0.02	-112.23
Free Cash Flow	< 0.005	-0.10	-1526.42
Revenue	0.63	1.29	104.26
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.21	1.21	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	23.52	12.32	-47.62
Naive Interpretation	Member

06 - Financial Health · Weak

Rating